Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238


Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer.

Baba T, Uramoto H, Kuwata T, Chikaishi Y, Nakagawa M, So T, Hanagiri T, Tanaka F.

Interact Cardiovasc Thorac Surg. 2012 Jun;14(6):760-4. doi: 10.1093/icvts/ivs058. Epub 2012 Feb 27.


Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.

Nakagiri T, Sawabata N, Funaki S, Inoue M, Kadota Y, Shintani Y, Okumura M.

Interact Cardiovasc Thorac Surg. 2011 May;12(5):733-8. doi: 10.1510/icvts.2010.249896. Epub 2011 Feb 5.


Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.

Zheng H, Gao W, Fei K, Xie HK, Jiang GN, Ding JA, Li C, Chen C, Zhang L.

Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):447-54. doi: 10.1093/icvts/ivt265. Epub 2013 Jun 19.


The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.

Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH.

Ann Thorac Surg. 2008 Oct;86(4):1092-7. doi: 10.1016/j.athoracsur.2008.06.056.


Mediastinal lymph-nodes metastasis beyond the lobe-specific: an independent risk factor toward worse prognoses.

Sun Y, Gao W, Zheng H, Jiang G, Chen C, Zhang L.

Ann Thorac Cardiovasc Surg. 2014;20(4):284-91. Epub 2013 Jun 18.


Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.

Osarogiagbon RU, Allen JW, Farooq A, Berry A, O'Brien T.

Ann Thorac Surg. 2011 May;91(5):1486-92. doi: 10.1016/j.athoracsur.2010.11.065. Erratum in: Ann Thorac Surg. 2011 Oct;92(4):1556.


Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.

Lee JG, Lee CY, Park IK, Kim DJ, Park SY, Kim KD, Chung KY.

Ann Thorac Surg. 2008 Jan;85(1):211-5.


Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.

Gunluoglu MZ, Demir A, Turna A, Sansar D, Melek H, Dincer SI, Gurses A.

Ann Thorac Cardiovasc Surg. 2011;17(3):229-35.


Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.

Sakuraba M, Takahashi N, Oh S, Miyasaka Y, Inagaki T, Suzuki K.

Ann Thorac Cardiovasc Surg. 2011;17(2):124-9.


Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.

Nentwich MF, Bohn BA, Uzunoglu FG, Reeh M, Quaas A, Grob TJ, Perez D, Kutup A, Bockhorn M, Izbicki JR, Vashist YK.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):781-7. doi: 10.1016/j.jtcvs.2013.04.037. Epub 2013 Jun 15.


Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?

Tandberg DJ, Gee NG, Chino JP, D'Amico TA, Ready NE, Coleman RE, Kelsey CR.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):796-801. doi: 10.1016/j.jtcvs.2013.05.027. Epub 2013 Jul 16.


Prognostic factors after complete resection of pN2 non-small cell lung cancer.

Sonobe M, Date H, Wada H, Okubo K, Hamakawa H, Teramukai S, Matsumura A, Nakagawa T, Sumitomo S, Miyamoto Y, Okumura N, Takeo S, Kawakami K, Aoki M, Kosaka S; The Japan-Multinational Trial Organization.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):788-95. doi: 10.1016/j.jtcvs.2013.04.043. Epub 2013 Jun 27.


Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.

Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP.

Eur J Surg Oncol. 2006 Jun;32(5):583-7. Epub 2006 Apr 18.


Prognostic evaluation of nodal staging based on the new IASLC lymph node map for lung cancer.

Takamochi K, Oh S, Suzuki K.

Thorac Cardiovasc Surg. 2010 Sep;58(6):345-9. doi: 10.1055/s-0030-1249944. Epub 2010 Sep 7.


Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?

Kudo Y, Saji H, Shimada Y, Nomura M, Usuda J, Kajiwara N, Ohira T, Ikeda N.

Eur J Cardiothorac Surg. 2012 Sep;42(3):414-9. doi: 10.1093/ejcts/ezs065. Epub 2012 Mar 6.


Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, Jones DR, McKenna RJ, Landreneau RJ, Rusch VW, Putnam JB Jr.

J Thorac Cardiovasc Surg. 2011 Mar;141(3):662-70. doi: 10.1016/j.jtcvs.2010.11.008.


The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.

Sakao Y, Okumura S, Mingyon M, Uehara H, Ishikawa Y, Nakagawa K.

J Thorac Oncol. 2011 Mar;6(3):494-9. doi: 10.1097/JTO.0b013e31820b8891.


Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer.

Moroga T, Yamashita S, Tokuishi K, Miyawaki M, Anami K, Yamamoto S, Kawahara K.

Ann Thorac Cardiovasc Surg. 2012;18(2):89-94. Epub 2011 Nov 15.


Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.

Shien K, Toyooka S, Soh J, Okami J, Higashiyama M, Kadota Y, Maeda H, Hayama M, Chida M, Funaki S, Okumura M, Miyoshi S.

Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):791-6. doi: 10.1093/icvts/ivv062. Epub 2015 Mar 24.


Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.

Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):615-9. doi: 10.1016/j.jtcvs.2007.09.029. Epub 2008 Jan 11.

Items per page

Supplemental Content

Write to the Help Desk